President and Co-CEO of Althea, Dr. Magda Marquet, added, "Receiving Deloitte's Fast 50 award and the San Diego Business Journal's Fast 100 award for the fifth year in a row is affirmation that we are continuing to listen to our pharmaceutical and biotechnology clients' requests and meet their demands for flexibility, compliance and service in advancing their exciting products. We are grateful for the confidence our growing client base has placed in us, a confidence earned through the dedication and hard work of our employees."
About Althea Technologies, Inc.
Althea Technologies, a leading San Diego-based pharmaceutical services firm, provides critical manufacturing services that support researchers worldwide in their advancement of novel therapies and efforts to apply new genomic information. Althea's services include cGMP contract manufacturing of recombinant proteins, DNA-based therapeutics and vaccines, and aseptic filling. For more information, visit http://www.altheatech.com.
As used in this document, "Deloitte" means Deloitte LLP. Please see http://www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
About The San Diego Business Journal
The San Diego Business Journal is the area's number one source for local, late breaking business news. For over 29 years, the Business Journal has provided in-depth coverage of the banking and finance, real estate, technology, tourism, life sciences and local government sectors, with a healthy dose of small business coverage as well. For more information please visit http://www.sdbj.com.
|SOURCE Althea Technologies, Inc.|
Copyright©2008 PR Newswire.
All rights reserved